Enveric Biosciences Inc. (ENVB): Price and Financial Metrics
ENVB Price/Volume Stats
| Current price | $1.43 | 52-week high | $14.18 |
| Prev. close | $1.36 | 52-week low | $1.01 |
| Day low | $1.34 | Volume | 58,800 |
| Day high | $1.49 | Avg. volume | 1,944,107 |
| 50-day MA | $1.45 | Dividend yield | N/A |
| 200-day MA | $4.77 | Market Cap | 3.53M |
ENVB Stock Price Chart Interactive Chart >
Enveric Biosciences Inc. (ENVB) Company Bio
Enveric Biosciences Inc., formerly AMERI Holdings, Inc., is a patient-central biotechnology company. The Company is focused on enhancing lives of people affected by the side effects of cancer treatments, such as radiodermatitis and chemotherapy-induced peripheral neuropathy. The Company is engaged in leveraging its clinical developments derived from ... More
ENVB Price Returns
| 1-mo | 14.40% |
| 3-mo | -9.49% |
| 6-mo | -75.99% |
| 1-year | -88.66% |
| 3-year | -99.05% |
| 5-year | -99.95% |
| YTD | -73.40% |
| 2024 | -72.43% |
| 2023 | -37.50% |
| 2022 | -95.53% |
| 2021 | -78.17% |
| 2020 | N/A |
Loading social stream, please wait...